T
CLLS

TCWP’s Cellectis CLLS Stock Holding History

TCWP’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-325
Closed -$1K – 570
2022
Q1 		$1K Buy
+325
New +$1.79K ﹤0.01% 1472

Other funds holding CLLS

LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
B
Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

TCWP's CLLS Position: Q2 2022 in Review

TCWP sold out of Cellectis (CLLS) in Q2 2022, closing a stake of 325 shares — an estimated $1K sold.

TCWP first reported a position in CLLS in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 45 funds tracked by Wall St. Rank hold CLLS as of Q2 2022.

  • TCWP reported no remaining Cellectis position as of Q2 2022 after selling out during the quarter.
  • TCWP sold 325 Cellectis shares in Q2 2022, an estimated $1K.
  • TCWP first reported a position in Cellectis in Q1 2022 and held it in 1 quarter.
  • TCWP's Cellectis position peaked at $1K in Q1 2022.
  • 45 funds tracked by Wall St. Rank held Cellectis as of Q2 2022.

Based on TCWP's 13F filing for Q2 2022, filed 15 Aug 2022.